Status:
COMPLETED
Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Growth Hormone Treatment
Eligibility:
All Genders
15+ years
Brief Summary
Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and addr...
Detailed Description
Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and addr...
Eligibility Criteria
Inclusion
- Adolescents and young adults followed or having been followed by the endocrinology, gynecology and pediatric diabetology department of the Necker Enfants Malades hospital and treated with growth hormone because of their short stature.
- Patient who participated in the initial study.
- Patient having reached the final height during the last consultation (growth rate less than 1 cm / year and / or bone age ≥ 15 years for girls, ≥ 17 years for boys).
- Holders of parental authority, minor patients and adult patients informed and not opposed to their participation in the study.
Exclusion
- \- Refusal to participate in the study.
Key Trial Info
Start Date :
March 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 12 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05195437
Start Date
March 8 2022
End Date
October 12 2024
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015